Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Kojima

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Medicinal Chemistry|June 10, 2022
Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary FibrosisTomoki Takeuchi, Masato Hayashi, Tomoko Tamita, et al.
Human Cell|August 30, 2024
Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1Yuki Adachi, Rei Noguchi, Julia Osaki, et al.
Frontiers in Neurology|August 1, 2022
Case Report: Spontaneous Postpartum Quadruple Cervicocephalic Arterial Dissection With a Heterozygous <i>COL5A1</i> Variant of Unknown SignificanceTakeaki Imamura, Takaki Omura, Nobuo Sasaki, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of TP0628103: A Highly Potent and Selective MMP-7 Inhibitor with Reduced OATP-Mediated Clearance Designed by Shifting Isoelectric PointsYusuke Oka, Kumi Abe-Sato, Hideaki Tabuse, et al.
Journal of Medicinal Chemistry|November 1, 2022
Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 InhibitionMadoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, et al.
Human Cell|March 11, 2024
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1Yuki Adachi, Rei Noguchi, Yuki Yoshimatsu, et al.
Bioorganic & Medicinal Chemistry|November 4, 2024
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F2Madoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Medicinal Chemistry|June 10, 2022
Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary FibrosisTomoki Takeuchi, Masato Hayashi, Tomoko Tamita, et al.
Human Cell|August 30, 2024
Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1Yuki Adachi, Rei Noguchi, Julia Osaki, et al.
Frontiers in Neurology|August 1, 2022
Case Report: Spontaneous Postpartum Quadruple Cervicocephalic Arterial Dissection With a Heterozygous <i>COL5A1</i> Variant of Unknown SignificanceTakeaki Imamura, Takaki Omura, Nobuo Sasaki, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of TP0628103: A Highly Potent and Selective MMP-7 Inhibitor with Reduced OATP-Mediated Clearance Designed by Shifting Isoelectric PointsYusuke Oka, Kumi Abe-Sato, Hideaki Tabuse, et al.
Journal of Medicinal Chemistry|November 1, 2022
Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 InhibitionMadoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, et al.
Human Cell|March 11, 2024
Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1Yuki Adachi, Rei Noguchi, Yuki Yoshimatsu, et al.
Bioorganic & Medicinal Chemistry|November 4, 2024
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F2Madoka Kawamura, Yohei Kobashi, Hiroaki Tanaka, et al.
Pageof 7